Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s Witness

Detalhes bibliográficos
Autor(a) principal: Carp, Maria
Data de Publicação: 2021
Outros Autores: Maurício, Sandra, Lança, Filipa
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763
Resumo: Postpartum Hemorrhage is still the leading cause of maternal mortality. The management of patients who refuse allogeneic blood transfusion, like in the case of Jehovah’s Witnesses, is clinically and ethically challenging. We describe the case of a woman with several risk factors for major postpartum hemorrhage, specifically the presence of a giant uterine myoma. The multidisciplinary management of this patient included an elective c-section and the use of prophylactic tranexamic acid. The perioperative and peripartum care of Jehovah’s Witnesses requires specific strategies to minimize blood loss, optimize oxygen delivery and consumption, enhance hemoglobin production, correct coagulation defects and promote hemostasis. We highlight the need for a multidisciplinary approach, point-of-care testing and the use of fibrinogen concentrate and tranexamic acid, according to the patients’ informed consent.
id RCAP_7d7eb3034291dc2f63cbc17278011390
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/12763
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s WitnessCirurgia Obstétrica com Risco Hemorrágico Major em Testemunha de JeováJehovah’s WitnessesPostpartum Hemorrhage/prevention & controlTranexamic AcidÁcido TranexâmicoHemorragia Pós-Parto/prevenção e controloTestemunhas de JeováPostpartum Hemorrhage is still the leading cause of maternal mortality. The management of patients who refuse allogeneic blood transfusion, like in the case of Jehovah’s Witnesses, is clinically and ethically challenging. We describe the case of a woman with several risk factors for major postpartum hemorrhage, specifically the presence of a giant uterine myoma. The multidisciplinary management of this patient included an elective c-section and the use of prophylactic tranexamic acid. The perioperative and peripartum care of Jehovah’s Witnesses requires specific strategies to minimize blood loss, optimize oxygen delivery and consumption, enhance hemoglobin production, correct coagulation defects and promote hemostasis. We highlight the need for a multidisciplinary approach, point-of-care testing and the use of fibrinogen concentrate and tranexamic acid, according to the patients’ informed consent.A hemorragia obstétrica continua a ser a principal causa de morbimortalidade materna, sendo que a abordagem de grávidas que recusam alotransfusão, como é o caso das Testemunhas de Jeová, coloca importantes questões médicas, éticas e legais. Reporta-se um caso de uma doente Testemunha de Jeová, submetida a cesariana com fatores de risco para hemorragia major, incluindo existência de um mioma gigante, em que se evitou a transfusão e foi utilizado ácido tranexâmico profilático. A abordagem de Testemunhas de Jeová em contexto de cirurgia obstétrica com risco hemorrágico major implica a definição de estratégias anestésico-cirúrgicas para a minimização de perdas hemorrágicas, a otimização da entrega e consumo de oxigénio, o aumento da síntese de hemoglobina, a correção de defeitos de coagulação e melhoria da hemostase. Revemos a importância do planeamento multidisciplinar, o recurso ao tromboelastrograma e a administração precoce de fibrinogénio e ácido tranexâmico, de acordo com o consentimento informado das doentes.Ordem dos Médicos2021-03-31info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfimage/jpegimage/jpegapplication/pdfapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763oai:ojs.www.actamedicaportuguesa.com:article/12763Acta Médica Portuguesa; Vol. 34 No. 4 (2021): April; 300-303Acta Médica Portuguesa; Vol. 34 N.º 4 (2021): Abril; 300-3031646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/6309https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11803https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11804https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11810https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11877https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11878https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11969https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11992Direitos de Autor (c) 2021 Acta Médica Portuguesainfo:eu-repo/semantics/openAccessCarp, MariaMaurício, SandraLança, Filipa2022-12-20T11:06:42Zoai:ojs.www.actamedicaportuguesa.com:article/12763Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:20:13.926342Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s Witness
Cirurgia Obstétrica com Risco Hemorrágico Major em Testemunha de Jeová
title Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s Witness
spellingShingle Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s Witness
Carp, Maria
Jehovah’s Witnesses
Postpartum Hemorrhage/prevention & control
Tranexamic Acid
Ácido Tranexâmico
Hemorragia Pós-Parto/prevenção e controlo
Testemunhas de Jeová
title_short Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s Witness
title_full Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s Witness
title_fullStr Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s Witness
title_full_unstemmed Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s Witness
title_sort Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s Witness
author Carp, Maria
author_facet Carp, Maria
Maurício, Sandra
Lança, Filipa
author_role author
author2 Maurício, Sandra
Lança, Filipa
author2_role author
author
dc.contributor.author.fl_str_mv Carp, Maria
Maurício, Sandra
Lança, Filipa
dc.subject.por.fl_str_mv Jehovah’s Witnesses
Postpartum Hemorrhage/prevention & control
Tranexamic Acid
Ácido Tranexâmico
Hemorragia Pós-Parto/prevenção e controlo
Testemunhas de Jeová
topic Jehovah’s Witnesses
Postpartum Hemorrhage/prevention & control
Tranexamic Acid
Ácido Tranexâmico
Hemorragia Pós-Parto/prevenção e controlo
Testemunhas de Jeová
description Postpartum Hemorrhage is still the leading cause of maternal mortality. The management of patients who refuse allogeneic blood transfusion, like in the case of Jehovah’s Witnesses, is clinically and ethically challenging. We describe the case of a woman with several risk factors for major postpartum hemorrhage, specifically the presence of a giant uterine myoma. The multidisciplinary management of this patient included an elective c-section and the use of prophylactic tranexamic acid. The perioperative and peripartum care of Jehovah’s Witnesses requires specific strategies to minimize blood loss, optimize oxygen delivery and consumption, enhance hemoglobin production, correct coagulation defects and promote hemostasis. We highlight the need for a multidisciplinary approach, point-of-care testing and the use of fibrinogen concentrate and tranexamic acid, according to the patients’ informed consent.
publishDate 2021
dc.date.none.fl_str_mv 2021-03-31
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763
oai:ojs.www.actamedicaportuguesa.com:article/12763
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/12763
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/6309
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11803
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11804
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11810
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11877
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11878
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11969
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11992
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2021 Acta Médica Portuguesa
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2021 Acta Médica Portuguesa
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
image/jpeg
image/jpeg
application/pdf
application/pdf
application/vnd.openxmlformats-officedocument.wordprocessingml.document
application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 34 No. 4 (2021): April; 300-303
Acta Médica Portuguesa; Vol. 34 N.º 4 (2021): Abril; 300-303
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130651039891456